Related Experiment Videos

[The mechanism of apoptosis induced by anticancer agents in human leukemia cells]

A Yoshida1, T Ueda

  • 1First Department of Internal Medicine, Fukui Medical School.

Insights

Anticancer drugs trigger apoptosis in leukemia cells like HL-60 and U937. Protease inhibitors suggest serine proteases are key in DNA fragmentation during this programmed cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Context:

  • Anticancer agents are known to induce apoptosis (programmed cell death) in human leukemia cells.
  • HL-60 and U937 cell lines are particularly sensitive to apoptosis induction by various chemotherapeutic drugs.
  • Internucleosomal DNA cleavage is a hallmark of apoptosis.

Purpose:

  • To investigate the role of proteases in anticancer agent-induced apoptosis in human myeloid leukemia cells.
  • To elucidate the mechanism by which serine protease inhibitors and ICE-like protease inhibitors affect DNA fragmentation.

Summary:

  • Treatment of HL-60 and U937 cells with etoposide, camptothecin, and ara-C induced internucleosomal DNA cleavage, a key event in apoptosis.
  • TPCK (a serine protease inhibitor) and VAD-FMK (an ICE-like protease inhibitor) significantly prevented this DNA cleavage.
  • Experiments in a cell-free system confirmed the inhibitory effects of these proteases on DNA fragmentation.

Impact:

  • Serine and ICE-like proteases are implicated in different stages of anticancer agent-induced apoptosis.
  • A serine protease appears to be critically involved in the final DNA fragmentation step of apoptosis in these leukemia cell lines.
  • This research provides insights into the molecular mechanisms underlying chemotherapy-induced apoptosis, potentially aiding in the development of targeted therapies.

Related Concept Videos